BRPI0820744A2 - Prevenção e tratamento de otite média usando leite enriquecido com iga - Google Patents

Prevenção e tratamento de otite média usando leite enriquecido com iga

Info

Publication number
BRPI0820744A2
BRPI0820744A2 BRPI0820744-5A2A BRPI0820744A BRPI0820744A2 BR PI0820744 A2 BRPI0820744 A2 BR PI0820744A2 BR PI0820744 A BRPI0820744 A BR PI0820744A BR PI0820744 A2 BRPI0820744 A2 BR PI0820744A2
Authority
BR
Brazil
Prior art keywords
prevention
average
treatment
enriched milk
iga enriched
Prior art date
Application number
BRPI0820744-5A2A
Other languages
English (en)
Inventor
Harald Bruessow
Nanda De Groot
Marie-Claire Fichot
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of BRPI0820744A2 publication Critical patent/BRPI0820744A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Gram-negative bacteria
    • C07K16/1214—Pseudomonadaceae (F)
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Gram-negative bacteria
    • C07K16/1242—Gram-negative bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Gram-positive bacteria
    • C07K16/1275—Streptococcus (G)
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/12—Immunoglobulins specific features characterized by their source of isolation or production isolated from milk

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Pediatric Medicine (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
BRPI0820744-5A2A 2007-12-11 2008-12-08 Prevenção e tratamento de otite média usando leite enriquecido com iga BRPI0820744A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07122885 2007-12-11
PCT/EP2008/067027 WO2009074539A1 (en) 2007-12-11 2008-12-08 Prevention and treatment of otitis media using iga enriched milk

Publications (1)

Publication Number Publication Date
BRPI0820744A2 true BRPI0820744A2 (pt) 2014-12-23

Family

ID=39339927

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0820744-5A2A BRPI0820744A2 (pt) 2007-12-11 2008-12-08 Prevenção e tratamento de otite média usando leite enriquecido com iga

Country Status (10)

Country Link
US (1) US20100303830A1 (pt)
EP (1) EP2222192A1 (pt)
CN (1) CN101938912A (pt)
AU (1) AU2008334671A1 (pt)
BR (1) BRPI0820744A2 (pt)
CA (1) CA2708792A1 (pt)
MX (1) MX2010006408A (pt)
RU (1) RU2010128562A (pt)
WO (1) WO2009074539A1 (pt)
ZA (1) ZA201004861B (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200716664A (en) * 2005-05-10 2007-05-01 Murray Goulburn Coop Co Ltd Immunoglobulin fraction and process therefor
MX2008015950A (es) * 2006-06-13 2009-01-09 Nestec Sa Prevencion y tratamiento de la otitis media.
AU2013265203B2 (en) * 2012-05-25 2017-09-07 Gottfried Himmler Secretory immunoglobulin deficiency treatment and prophlaxis
US9458230B2 (en) * 2013-01-04 2016-10-04 Wisconsin Alumni Research Foundation Secretory IGA compositions, methods of making and methods of use thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI955389A0 (fi) * 1995-11-09 1995-11-09 Antti Sakari Aaltonen Tandskyddande profylaktisk preparat och administreringsmedlen emot mellanoerpatogener
EP0990001B1 (en) * 1997-05-29 2006-05-10 Agresearch Limited Processes for production of immunoglobulin a in milk
AU2002367161A1 (en) * 2001-12-24 2003-07-15 Fonterra Co-Operative Group Limited Immunoglobulin composition
MX2008015950A (es) * 2006-06-13 2009-01-09 Nestec Sa Prevencion y tratamiento de la otitis media.

Also Published As

Publication number Publication date
RU2010128562A (ru) 2012-01-20
EP2222192A1 (en) 2010-09-01
US20100303830A1 (en) 2010-12-02
CA2708792A1 (en) 2009-06-18
MX2010006408A (es) 2010-10-20
AU2008334671A1 (en) 2009-06-18
WO2009074539A1 (en) 2009-06-18
CN101938912A (zh) 2011-01-05
ZA201004861B (en) 2011-12-28

Similar Documents

Publication Publication Date Title
NO2022027I1 (no) Combination of daunorubicin and cytarabine
BRPI0907422A2 (pt) Composições de limpeza e/ou tratamento
PL2037902T3 (pl) Zastosowanie kanabidiolu w użyciu w leczeniu bólu neuropatycznego
DE602007002740D1 (de) Trokar und Behandlungssystem
BRPI0816836A2 (pt) Composições de limpeza e/ou tratamento
PL2583978T3 (pl) Profilaktyka i leczenie chorób synukleinopatycznych i amyloidogennych
BRPI0907135A2 (pt) Processos de tratamento de dor crônica
BRPI0916125A2 (pt) "dispositivo de tratamento"
BRPI0820882A2 (pt) Dispositivos e métodos de estimulação de dermátomo
PT2099321T (pt) Composições de leite humano e métodos de fabrico e utilização das mesmas
IL210810A0 (en) Compositions for the treatment of pain and/or inflamtion
BRPI0716466A2 (pt) Tratamento da calda de açúcar
CR9878A (es) Tratamiento y profilaxis de microangiopatias
BRPI0820477A2 (pt) Compostos de benzodiazepinona úteis no tratamento de afecções da pele
SI2114447T1 (sl) Preprečevanje in zdravljenje subklinične PCVD
BRPI0811870A2 (pt) Tratamento e prevenção de influenza
EP2106253A4 (en) TREATMENT OF ACOUPHEN
EP3381471C0 (en) PAIN TREATMENT
PT3067066T (pt) Prevenção e tratamento da doença sinucleinopática e amiloidogénica
GB0610350D0 (en) prevention and/or treatment of neuodegenerative disorders
BRPI0810475A2 (pt) uso de dimiracetam no tratamento de dor crônica
BR112012006005A2 (pt) "peptídeos no tratamento de transtorno associados ao estresse oxidativo"
BRPI0820449A2 (pt) Conjunto de implante médico interfaceado
PL3156057T3 (pl) Powlekany delmopinolem gryzak dla zwierząt do stosowania w zapobieganiu lub leczeniu halitozy
PT2341900T (pt) Produto medicinal e tratamento

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 5A, 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2343 DE 01-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.

B15K Others concerning applications: alteration of classification

Ipc: C07K 16/12 (2006.01), A23L 33/135 (2016.01), A23L